Logan Lutton

In this video interview, Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.

Adults in rural Appalachian Kentucky are facing a severe sleep crisis when compared to the rest of the country, a trend exacerbated by income inequality

Per- and polyfluoroalkyl substances seem to be associated with a high risk of reduced fertility, as well as maternal health concerns such as preeclampsia and gestational diabetes.

Nearly all U.S. adolescents who are at risk for HIV are missing out on preexposure prophylaxis, with significant disparities in access based on age, gender and geographic location.

New research suggests that when adolescents sleep, not just how long, may play a significant role in shaping their eating habits and activity levels, particularly during the school year.

Dermatology performance measures need to be streamlined and redesigned to better capture meaningful patient outcomes while reducing administrative burden and aligning with value-based care.

Women who experience menopause before age 40 face a significantly higher risk of coronary heart disease, according to new research by researchers at Northwestern Medicine.

Doctors Without Borders has accused Gilead of restricting access to its HIV prevention drug lenacapavir by refusing humanitarian sales and limiting supply, arguing this is hindering global efforts to expand HIV prevention in high-need regions.

Alkermes has initiated a phase 3 clinical program evaluating alixorexton for narcolepsy type 1 and type 2, with additional development underway for idiopathic hypersomnia.

Incyte’s phase 3 STOP-HS data show that povorcitinib improved symptoms of moderate to severe hidradenitis suppurativa in most patients over 54 weeks with a generally well-tolerated safety profile.

Sunlight can be both harmful and beneficial, meaning it’s important for dermatologists to give personalized advice to each patient, according to this morning’s 2026 American Academy of Dermatology session

Arthropods can cause or mimic a wide range of skin diseases, making accurate recognition, diagnosis and management essential in dermatologic care.

This afternoon’s session emphasized evolving vitiligo management strategies focused on emerging immune-targeted treatments, alongside a growing emphasis on holistic, patient-centered care.

At the American Academy of Dermatology 2026 meeting, dermatology leaders emphasized the growing need for advocacy to address rural access disparities and the escalating impact of climate change on patient care and health systems.

The 2026 American Academy of Dermatology meeting began today in Denver, featuring a keynote conversation this evening with John Legend on wellness, identity and his Loved01 skincare brand.

Vitiligo is a chronic autoimmune disease that affects skin pigmentation and, while not painful or contagious, requires greater attention in managed care due to its long-term nature and psychosocial impact.

A childhood teacher once told Rachel Moseley, Ph.D., there was “no point” in teaching her math. Since then, she has graduated from Cambridge University in England with a doctorate in cognitive neuroscience. She and a colleague have recently published a book of interviews exploring menopause among people with autism.

UnitedHealthcare is expanding access to doula services through eligible employer-sponsored plans, aiming to improve maternal health outcomes and provide more comprehensive pregnancy support.

In this conversation, Kirk Grisham, M.P.H., and Vishakh Unnikrishnan, M.P.H., both from the Center for HIV and Infectious Disease Policy at the O’Neill Institute, explain how federal funding cuts are destabilizing state HIV programs and why state leadership and political will now largely determine whether people keep access to HIV prevention and care.

The Department of Health and Human Services is celebrating Match Day early by providing more than $5 million in funding to Teaching Health Center Graduate Medical Education programs, supporting approximately 100 residents training in underserved and rural communities.

The FDA has approved Icotyde as the first and only IL-23R targeted oral peptide for the treatment of moderate-to-severe plaque psoriasis.

In Florida, abrupt cuts to HIV medication and insurance support are forcing patients off trusted regimens, exposing dangerous coverage gaps, and illustrating how policy decisions can quietly drive up both human and financial costs in the U.S. healthcare system.

A new research review suggests menopause may worsen obsessive-compulsive disorder symptoms for some women, with more than a quarter reporting increased severity during the transition.

The FDA has approved Cosentyx as the first interleukin-17A (IL-17A) inhibitor approved for pediatric hidradenitis suppurativa.

Women going through perimenopause who feel lonely and socially isolated are more likely to report memory and cognitive difficulties than those who report neither, with the highest risk seen in those experiencing both.

The FDA has approved Sotyktu (deucravacitinib) as the first selective TYK2 inhibitor for adults with active psoriatic arthritis.

A study published in Substance Use and Addiction found that combining nicotine replacement therapy with a rewards-based contingency management program helped people with HIV achieve higher short-term smoking cessation rates than nicotine replacement therapy alone.

Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 other states consider similar cuts amid rising program costs and stagnant federal funding.

A recent American Cancer Society study found that colorectal cancer is increasingly common, especially in adults under 50. Test your current knowledge with this slideshow and learn what you can be doing to prevent it.